Rocket Pharmaceuticals, Inc. (RCKT)
NGM · Common · CUSIP 45780V102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RCKT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45780V102
Market Cap
Small Cap
IPO
2/17/2015 · $6.00/share
Previous Symbol
ITEK
Previous Name
Inotek Pharmaceuticals Corp.
Business: Inotek Pharmaceuticals Corp. is a clinical-stage, privately held, biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat glaucoma and other serious diseases of the eye.
Notes: 2/18/2015 -- Concurrent with the IPO stock offering listed on the NASDAQ (NGS) the Company is also offering $20 million of 5.00% Convertible Senior Notes due 2020 that will not be listed on any market exchange.

Company Contact

CEO
Gaurav Shah
CFO
John Militello
Headquarters
9 Cedarbrook Drive, Cranbury, NJ 08512
Phone
609-659-8001
Investor Relations
Jessie Yeung · 646-440-9100 · investors@rocketpharma.com
General Email
info@inotekpharma.com
SEC EDGAR Filings
View filings »